These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31180183)

  • 1. Kinetic modeling as a tool to understand the influence of cell culture process parameters on the glycation of monoclonal antibody biotherapeutics.
    Agarwal N; Mason A; Pradhan R; Kemper J; Bosley A; Serfiotis-Mitsa D; Wang J; Lindo V; Ahuja S; Hatton D; Savery J; Miro-Quesada G
    Biotechnol Prog; 2019 Sep; 35(5):e2865. PubMed ID: 31180183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody glycation during a Chinese hamster ovary fed-batch process is following a constrained second order reaction.
    Pappenreiter M; Lhota G; Vorauer-Uhl K; Sissolak B
    Biotechnol Prog; 2022 Sep; 38(5):e3261. PubMed ID: 35429153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling the time evolution of mAb N-linked glycosylation - Part II: Model-based predictions.
    Villiger TK; Scibona E; Stettler M; Broly H; Morbidelli M; Soos M
    Biotechnol Prog; 2016 Sep; 32(5):1135-1148. PubMed ID: 27273889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling glycation of recombinant antibody in fed-batch cell cultures.
    Yuk IH; Zhang B; Yang Y; Dutina G; Leach KD; Vijayasankaran N; Shen AY; Andersen DC; Snedecor BR; Joly JC
    Biotechnol Bioeng; 2011 Nov; 108(11):2600-10. PubMed ID: 21618472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation and modeling of monoclonal antibody N-linked glycosylation in mammalian cell perfusion reactors.
    Karst DJ; Scibona E; Serra E; Bielser JM; Souquet J; Stettler M; Broly H; Soos M; Morbidelli M; Villiger TK
    Biotechnol Bioeng; 2017 Sep; 114(9):1978-1990. PubMed ID: 28409838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A semi-empirical glycosylation model of a camelid monoclonal antibody under hypothermia cell culture conditions.
    Aghamohseni H; Spearman M; Ohadi K; Braasch K; Moo-Young M; Butler M; Budman HM
    J Ind Microbiol Biotechnol; 2017 Jul; 44(7):1005-1020. PubMed ID: 28285402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of glycated IgG in CHO supernatants: A practical approach.
    Lhota G; Sissolak B; Striedner G; Sommeregger W; Vorauer-Uhl K
    Biotechnol Prog; 2021 May; 37(3):e3124. PubMed ID: 33428326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling the time evolution of mAb N-linked glycosylation, Part I: Microbioreactor experiments.
    Villiger TK; Roulet A; Périlleux A; Stettler M; Broly H; Morbidelli M; Soos M
    Biotechnol Prog; 2016 Sep; 32(5):1123-1134. PubMed ID: 27254475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does mild hypothermia affect monoclonal antibody glycosylation?
    Sou SN; Sellick C; Lee K; Mason A; Kyriakopoulos S; Polizzi KM; Kontoravdi C
    Biotechnol Bioeng; 2015 Jun; 112(6):1165-76. PubMed ID: 25545631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An empirical modeling platform to evaluate the relative control discrete CHO cell synthetic processes exert over recombinant monoclonal antibody production process titer.
    McLeod J; O'Callaghan PM; Pybus LP; Wilkinson SJ; Root T; Racher AJ; James DC
    Biotechnol Bioeng; 2011 Sep; 108(9):2193-204. PubMed ID: 21445882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic development of temperature shift strategies for Chinese hamster ovary cells based on short duration cultures and kinetic modeling.
    Xu J; Tang P; Yongky A; Drew B; Borys MC; Liu S; Li ZJ
    MAbs; 2019 Jan; 11(1):191-204. PubMed ID: 30230966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of cell culture process parameters for modulating mAb afucosylation.
    Nguyen Dang A; Mun M; Rose CM; Ahyow P; Meier A; Sandoval W; Yuk IH
    Biotechnol Bioeng; 2019 Apr; 116(4):831-845. PubMed ID: 30597531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of glycation and its impact on antigen binding.
    Mo J; Jin R; Yan Q; Sokolowska I; Lewis MJ; Hu P
    MAbs; 2018 Apr; 10(3):406-415. PubMed ID: 29436927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the Effect of Amino Acids and Copper on Monoclonal Antibody Productivity and Glycosylation: A Modular Approach.
    Luo Y; Lovelett RJ; Price JV; Radhakrishnan D; Barnthouse K; Hu P; Schaefer E; Cunningham J; Lee KH; Shivappa RB; Ogunnaike BA
    Biotechnol J; 2021 Feb; 16(2):e2000261. PubMed ID: 32875683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating cell culture oxidative stress reduces protein glycation and acidic charge variant formation.
    Chung S; Tian J; Tan Z; Chen J; Zhang N; Huang Y; Vandermark E; Lee J; Borys M; Li ZJ
    MAbs; 2019 Jan; 11(1):205-216. PubMed ID: 30602334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raman based chemometric model development for glycation and glycosylation real time monitoring in a manufacturing scale CHO cell bioreactor process.
    A Gibbons L; Rafferty C; Robinson K; Abad M; Maslanka F; Le N; Mo J; Clark K; Madden F; Hayes R; McCarthy B; Rode C; O'Mahony J; Rea R; O'Mahony Hartnett C
    Biotechnol Prog; 2022 Mar; 38(2):e3223. PubMed ID: 34738336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dynamic mathematical model for monoclonal antibody N-linked glycosylation and nucleotide sugar donor transport within a maturing Golgi apparatus.
    Jimenez del Val I; Nagy JM; Kontoravdi C
    Biotechnol Prog; 2011; 27(6):1730-43. PubMed ID: 21956887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of mammalian cell culture conditions on monoclonal antibody charge heterogeneity: an accessory monitoring tool for process development.
    Sissolak B; Lingg N; Sommeregger W; Striedner G; Vorauer-Uhl K
    J Ind Microbiol Biotechnol; 2019 Aug; 46(8):1167-1178. PubMed ID: 31175523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quick generation of Raman spectroscopy based in-process glucose control to influence biopharmaceutical protein product quality during mammalian cell culture.
    Berry BN; Dobrowsky TM; Timson RC; Kshirsagar R; Ryll T; Wiltberger K
    Biotechnol Prog; 2016; 32(1):224-34. PubMed ID: 26587969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization and kinetic modeling of interchain disulfide bond reoxidation of monoclonal antibodies in bioprocesses.
    Tang P; Tan Z; Ehamparanathan V; Ren T; Hoffman L; Du C; Song Y; Tao L; Lewandowski A; Ghose S; Li ZJ; Liu S
    MAbs; 2020; 12(1):1829336. PubMed ID: 33031716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.